Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine if patients with hip fractures who undergo cryoablation of the PENG have improved pain control 30 days from surgery when compared to those who have a fascia iliaca catheter.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| PENG block and cryoablation | Experimental | Patients undergoing hip fracture repair aged 18-85 |
|
| fascia iliaca compartment block | Experimental | Patients undergoing hip fracture repair aged 18-85 |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| PENG block and cryoablation | Drug | will receive an ultrasound guided PENG block with 20 mL of 0.5% bupivacaine followed by cryoablation of the PENG nerves. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Maximum pain score on Post-operative day 30 | Maximum pain score on day 30 post surgery. Pain Scale is 0-10 with 0 meaning no pain (better outcome) and 10 meaning worst pain imaginable (worse outcome). | 30 days post surgery |
| Opioid use | Opioid use and Functional Pain scores on POD 0, 1, 2, 3, 4, 5, 6, 7 - measured in milligrams morphine equivalents | day 0, 1, 2, 3, 4, 5, 6, 7 post surgery |
| functional pain scores | Functional Pain Score on Post Operative Day 0, 1, 2, 3, 4, 5, 6, 7 - measured with Pain Scale 0-10 with 0 meaning no pain (better outcome) and 10 meaning worst pain imaginable (worse outcome) | day 0, 1, 2, 3, 4, 5, 6, 7 post surgery post surgery |
| number of patients using opioids | measured in number of patients | 30 days post surgery |
| Length of Hospital Stay | measured in number of days | 30 days post surgery |
| Time to first ambulation | measured in Days:Hours:Minutes post operation | 30 days post surgery |
| Number of patients returned home by Post Operative Day 30 | measured in number of patients | 30 days post surgery |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Candace Nelson | Contact | nelso377@umn.edu |
| Name | Affiliation | Role |
|---|---|---|
| Jason Habeck | University of Minnesota | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Minnesota | Recruiting | Minneapolis | Minnesota | 55414 | United States |
Not provided
| ID | Term |
|---|---|
| D006620 | Hip Fractures |
| ID | Term |
|---|---|
| D005264 | Femoral Fractures |
| D050723 | Fractures, Bone |
| D014947 | Wounds and Injuries |
| D025981 | Hip Injuries |
Not provided
Not provided
| ID | Term |
|---|---|
| D003452 | Cryosurgery |
| ID | Term |
|---|---|
| D055011 | Ablation Techniques |
| D013514 | Surgical Procedures, Operative |
Not provided
Not provided
This is a randomized prospective controlled trial. This will be single blinded trial. Randomization will be 1:1
Not provided
Not provided
Not provided
Not provided
| fascia iliaca compartment block | Drug | will receive an ultrasound guided fascia iliaca compartment catheter with initial bolus of 20 mL of 0.5% bupivacaine followed by infusion of 0.2% ropivacaine at 10 mL per hour |
|
| D007869 |
| Leg Injuries |